Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

Introduction: SDHB pathogenic variants predispose to aggressive and metastatic paragangliomas (mPGLs). International consensus recommends temozolomide treatment (low-grade evidence). Capecitabine and temozolomide (CAPTEM) has shown advantage over temozolomide in the treatment of neuroendocrine tumours (NETs). Evidence for its use in mPGLs remains scarce.

Conference:

Presenting Author: G. Martins R

Authors: Silva L, Martins R, Couto J, Garcia R, Martins Fernandes A,

Keywords: mPGL, SDHB, captem,

#3215 Mixed neuroendocrine non-neuroendocrine neoplasm of the ampulla of Vater: Case Report

Introduction: Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) is defined as a tumor composed of both neuroendocrine and non-neuroendocrine components. MiNEN of the ampulla of Vater is a rare neuroendocrine tumor of the gastrointestinal tract.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Caetano A

Authors: Caetano A, Sousa M, Elvas A, Monteiro A, Couto J,

Keywords: mixed neuroendocrine non-neuroendocrine neoplasm, MiNEN, ampulla of Vater, neuroendocrine tumor,

#2245 Metastatic VIPOMA, Co-Secreting Insulin, with Complete Response to Lanreotide Combined with Capecitabine and Temozolamide

Introduction: VIPomas are rare neuroendocrine tumors (NETs) associated with vasoactive intestinal polypeptide (VIP) hypersecretion causing watery diarrhea, hypokalaemia and achlorhydria. They originate mostly in the pancreas and 60-80% are malignant. Hormonal co-secretion is rarely reported.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Marques B

Authors: Marques B, Martins R, Ribeiro J, Couto J, Ferrão H,

Keywords: vipoma, neuroendocrine, lanreotide, capecitabine, temozolamide,

#1715 Recurrence of 6mm Rectal Neuroendocrine Tumor, 14 Years after Excision

Introduction: Rectal neuroendocrine tumours (NET) constitute 25% of all the digestive NET. Predictive factors of distant metastasis are: size greater than 1cm, high proliferative index and muscularis or lymphovascular invasion. In the absence of these criteria, some authors advocate there is no need for long-term follow-up.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Marques B

Authors: Marques B, Martins R, Cadime A, Marques M, Couto J,

Keywords: neuroendocrine, recurrence,

#960 Gastroenteropancreatic Neuroendocrine Neoplasms: The Experience of an Oncology Center

Introduction: Gastroenteropanceratic neuroendocrine neoplasms(GEP-NEN) are a heterogeneous group of tumors and an exponential increase in its incidence has been noticed over the past decades.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Santos A

Authors: Couto J, Santos A, Martins R, Antunes L, Violante L,

Keywords: neuroendocrine, neoplasia, survival,